Abstract
Vertebrates respond to infection and inflammation with a complex series of intercellular communication signals involving the immune, nervous, and endocrine systems. Recent investigations have shown that the immune system is subject to neural and endocrine control, and that it exerts in turn a reciprocal effect on the nervous system. In addition, the immune system is capable of producing neuropeptides, and the nervous system is able to secrete cytokines. This chapter summarizes the evidence for the production and function of neuropeptides in this regulatory relationship. The neuropeptides discussed here include corticotropin (ACTH), β-endorphin, vasoactive intestinal peptide (VIP), somatostatin (SOM), and substance P. Overall, a rapidly expanding body of evidence indicates that neuropeptides and cytokines are the common signal molecules that mediate bidirectional communication between the immune and neuroendocrine systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alvarez-Mon A, Kehrl JH, Fauci AS (1985) A potential role for adrenocorticotropin in regulating human B-lymphocyte functions. J Immunol 135: 3823–3826
Antoni FA (1986) Hypothalamic control of ACTH secretion. Endocr Rec 2: 351–378
Bar-Shavit Z, Goldman R, Stabinsky Y, Gottleib F, Fridkin M, Teichberg V, Blumberg S (1980) Enhancement of phagocytosis— a newly found activity of substance P residing in its N- terminal tetrapeptide sequence. Biochem Biophys Res Commun 94: 1445–1451
Bellinger DL, Lorton D, Romano TD, Olschowka JA, Felten SY, Felten DL (1990) Neuropeptide innervation of lymphoid organs. Ann NY Acad Sci 594: 17–33
Bessler H, Sztein MB, Serrate SA (1990) ß-Endorphin modulation of IL-1 induced IL-2 production. Immunopharmacology 19: 5–14
Bhathena SJ, Louie J, Schechter GP, Redman RS, Wahl L, Recant L (1981) Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes 30: 127–131
Blalock JE (1984) The immune system as a sensory organ. J Immunol 132: 1067–1070
Blalock JE, Smith EM (1980) Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci USA 77: 5972–5974
Bost KL, Blalock JE (1985) Molecular characterization of a corticotropin ( ACTH) receptor. Mol Cell Endocrinol 44: 1–9
Bozzola M, Moretta A, Maccario R, Bohen M, Burgio GR (1987) Modulating effect of growth hormone (GH) on in vitro lymphoproliferation. 1st European congress on endocrinology, Copenhagen, abstract no 148
Brown SL, Van Epps D (1986) Opioid peptides modulate production of interferon-y by human mononuclear cells. Cell Immunol 103: 19–26
Buzzetti R, McLoughlin L, Lavender PM, Clark AJL, Rees LH (1989) Expression of proopiomelanocortin gene and quantification of adrenocorticotropic hormone-like immuno-reactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 83: 733–737
Carr DJJ, Klimpel GR (1986) Enhancement of the generation of cytotoxic T-cells by endogenous opiates. J Neuroimmunol 12: 75–87
Carr DJJ, DeCosta BR, Jacobson AE, Rice KC, Blalock JE (1990) Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway. J Neuroimmunol 28: 53–61
Ferreira JA, Carstens ME, Taljaard JJF (1990) Quantitative determination of lymphocyte ACTH-1–39. Neuropeptides 15: 11–15
Foris G, Medgyesi GA, Gyimesi E, Hauck M (1984) Met-enkephalin induced alterations of macrophage functions. Mol Immunol 21: 747–750
Froelich OJ, Bankhurst AD (1984) The effect of beta-endorphin on natural cytotoxicity and antibody-dependent cellular cytotoxicity. Life Sci 35: 261–265
Fuller PJ, Verity K (1989) Somatostatin gene expression in the thymus gland. J Immunol 143: 1015–1017
Galin FS, LeBoeuf RD, Blalock JE (1991) Corticotropin releasing factor unregulates expression of two truncated pro-opiomelanocortin transcripts in lymphocytes. J Neuroimmunol 31: 51–58
Gibbons JM, Mitnick M, Chieffo V (1975) In vitro biosynthesis of TSH and LH-releasing factors by the human placenta. Am J Obstet Gynecol 121: 127–131
Gilman SC, Schwartz JM, Milner RJ, Bloom FE, Feldman JD (1982) ß-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA 79: 4226–4230
Goetzl EJ, Payan DG (1984) Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol 133: 3255–3259
Goetzl EJ, Chernov T, Renold F, Payan DG (1985) Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135: 8025–8055
Goetzl EJ, Sreedharan SP, Turck DW (1988) Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells. J Biol Chem 263: 9083–9086
Goetzl EJ, Grotmol T, Van Dyke RW, Turck CW, Wershil B, Galli Si, Sreedharan SP (1990a) Generation and recognition of vasoactive intestinal peptide by cells of the immune system. Ann NY Acad Sci 594: 34–44
Goetzl EJ, Adelman DC, Sreedharan SP (1990b) Neuroimmunology. In: Dixon FJ, Austen KF, Hood L, Uhr UW (eds) Advances in immunology. Academic Press, New York
Goetzl EJ, Turck C, Sreedharan S (1991) Production and recognition of neuropeptides by cells of the immune system. In: Ader R, Cohen N, Felten DL (eds) Psychoneuroimmunology, 2nd edn. Academic, New York, pp 263–282
Guerrero JM, Prieto JC, Elorza FL, Ramirez R, Goberna R (1981) Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol 21: 151–160
Hadjupetrou-Kourounakis L, Karagounis E, Rekka E, Kourounakis P (1989) Immunosuppression by a novel opioid agonist. Scand J Immunol 29: 449–458
Harbour DV, Smith EM, Blalock JE (1987) A novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone-cleaving enzyme. J Neurosci Res 18: 95–101
Harbour-McMenamin DV, Smith EM, Blalock JE (1985) Endotoxin induction of leukocyte-derived proopiomelanocortin related peptides. Infect Immun 48: 813–819
Hargreaves KM, Costello AH, Joris JL (1987) Release from inflamed tissue of a substance with properties similar to corticotropin-releasing factor. Neuroendocrinology 49: 476–482
Healy DL, Hodgen GD, Schulte HM, Chrousos GP, Loriaux DL, Hall NR, Goldstein AL (1983) The thymus adrenal connection: thymosin has corticotropin releasing activity in primates. Science 222: 1353–1355
Heijnen CJ, Bevers C, Kavelaars A, Ballieux RE (1986) Effect of a-endorphin on the antigen-induced primary antibody response of human blood B-cells in vitro. J Immunol 136: 213–216
Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C (1986) Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporin. Proc Natl Acad Sci USA 83: 2599–2603
Johnson HM, Torres BA (1985) Regulation of lymphokine production by arginine vasopressin and oxytocin: modulation of lymphocyte function by neurohypophyseal hormones. J Immunol 135: 773s - 775s
Johnson HM, Smith EM, Torres BA, Blalock JE (1982) Neuroendocrine hormone regulation of in vitro antibody production. Proc Natl Acad Sci USA 79: 4171–4174
Johnson HM, Torres BA, Smith EM, Dion LD, Blalock JE (1984) Regulation of lymphokine (interferon-y) production by corticotropin. J Immunol 132: 246–250
Kavelaars A, Ballieux RE, Heijnen CJ (1989) The role of IL-1 in the corticotropin-releasing factor and arginine vasopressin-induced secretion of immunoreactive ß-endorphin by human peripheral blood mononuclear cells. J Immunol 142: 2338–2342
Kavelaars A, Ballieux RE, Heijnen CJ (1990a) ß-Endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids. Life Sci 46: 1233–1240
Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE, Heijnen CJ (1990b) Induction of ß-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759–764
Khodr GS, Siler-Khodr TM (1980) Placental luteinizing hormone-releasing factor and its synthesis. Science 207: 315–317
Koff WC, Dunegan MA (1985) Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 135: 350–354
Kruger TE, Smith LR, Harbour DV, Blalock JE (1989) Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol 142: 744–747
Lolait SJ, Lim ATW, Toh BH, Funder JW (1984) Immunoreactive ß-endorphin in a subpopulation of mouse spleen macrophages. J Clin Invest 73: 277–280
Liolait SJ, Clements JA, Markwick AJ, Cheng C, McNally M, Smith AI, Funder JW (1986) Proopiomelanocortin messenger ribonucleic acid and posttranslational processing of ß-endorphin in spleen macrophages. J Clin Invest 77: 1776–1779
Lundbert JM, Saria A, Brodin E, Rossell S, Folkars K (1983) A substance P antagonist inhibits vagally-induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci USA 80: 1120–1124
Lygren I, Revhaug A, Burhol PG, Giercksky KE, Jenssen TG (1984) Vasoactive intestinal polypeptide and somatostatin in leucocytes. Scand J Clin Lab Invest 44: 347–351
Marchetti B, Guarcello V, Morale MC, Bartoloni G, Farinella Z, Cordaro S, Scapagnini U (1989) Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function. Endocrinology 125: 1025–1036
Marchetti B, Maier CC, LeBoeuf RD, Blalock JE (1990) Luteinizing hormone-releasing hormone gene expression in the thymus. Annual meeting of the society for Neuroscience, 28 Oct-2 Nov, 1990, St Louis, Missouri
Mathews PM, Froelich CJ, Sibbitt WL, Bankhurst AD (1983) Enhancement of natural cytotoxicity by ß-endorphin. J Immunol 130: 1658–1662
Mcllhinney RAJ, Schulster D (1975) Studies on the binding of 125I-labelled corticotropin to isolated rat adrenocortical cells. J Endocrinol 64: 175–184
Merrill JE, Kutsunai S, Mohlstrom C, Hofman F, Groopman J, Golde DW (1984) Proliferation of astroglia and oligodendroglia in response to human T-cell-derived factors. Science 224: 1428–1430
Moore TC (1984) Modification of lymphocyte traffic by vasoactive neurotransmitter substance. Immunology 52: 511–518
Oates EL, Allaway GP, Armstrong GR, Boyajian RA, Kehrl JH, Prabhakar BS (1988) Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. J Biol Chem 263: 10041–10044
Oleson DR, Johnson DR (1988) Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav Immun 2: 171–186
Ottaway CA (1984) In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T-cells. J Exp Med 160: 1054–1069
Ottaway CA, Greenberg GR (1984) Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol 132: 417–423
Pawlikowski M, Stepien H, Kunert-Radek J, Schally AV (1985) Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro. Biochem Biophys Res Commun 129: 52–55
Pawlikowski M, Zelazowski P, Dohler KD, Stepien H (1988) Effects of two neuropeptides: Somatoliberin (GHRH) and corticoliberin ( CRF) on human lymphocyte natural killer activity. Brain Behav Immun 2: 50–56
Payan DG, Brewster DR, Goetzl EJ (1983) Specific stimulation of human T-lymphocytes by substance P. J Immunol 131: 1613–1615
Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ (1984a) Substance P recognition by a subset of human T-lymphocytes. J Clin Invest 74: 1532–1539
Payan DG, Hess CA, Goetzl EJ (1984b) Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol 84: 433–438
Payan DG, Levine JD, Goetzl EJ (1984c) Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 132: 1601–1604
Piotrowski W, Mead M, Foreman JC (1987) Action of the SP2–11 and SP3–11 fragments of substance P on rat peritoneal mast T-cells. Agents Actions 20: 178–180
Rivier CL, Plotsky PM (1986) Mediation by corticotropin-releasing factor of adenohypophysial hormone secretion. Annu Rev Physiol 48: 475–494
Rola-Pleszczynski M, Bulduc D, St Pierre A (1985) The effects of VIP on human NK cell function. J Immunol 135: 2659–2673
Ruff MR, Wahl SM, Pert CB (1985) Substance P receptor-mediated chemotaxis of human monocytes. Peptides 6: 107–111
Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, Go M, Shimizu Y, Hanew K, Yoshinaga K (1987) Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab 64: 224–229
Sasaki A, Shuichi S, Shigeru Y, Hanew K, Miru Y, Yoshinaga K (1989) Multiple forms of immunoreactive growth hormone-releasing hormone in human plasma, hypothalamus, and tumor tissues. J Clin Endocrinol Metab 68: 180–185
Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D (1985) Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135: 1331–1337
Shibasaki.T, Odagiri E, Shizume K, Rainey N (1982) Corticotropin-releasing factor-like activity in human placental extracts. J Clin Endocrinol Metab 55: 384–386
Shibasaki T, Kiyosawa Y, Masuda A, Nakahara M, Imaki T, Wakabayashi I, Demura H, Shizume K, Ling N (1984) Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts. J Clin Endocrinol Metab 59: 263–268
Singh VK (1989) Stimulatory effect of corticotropin releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol 23: 257–262
Smith EM, Blalock JE (1981) Human lymphocyte production of ACTH and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci USA 78: 7530–7534
Smith EM, Meyer WJ, Blalock JE (1982) Virus induced increases in corticosterone in hypophysectomy mice: a possible lymphoid-adrenal axis. Science 218: 1311–1313
Smith EM, Phan M, Coppenhaver D, Kruger TE, Blalock JE (1983) Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci USA 80: 6010–6013
Smith EM, Morrill AC, Meyer,WJ, Blalock JE (1986) Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 322: 881–882
Smith EM, Galin FS, LeBoeuf RD, Copenhaver DH, Harbour DV, Blalock JE (1990) Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of truncated peptide. Proc Natl Acad Sci USA 87: 1057–1060
Stanisz AM, Befus D, Bienenstock J (1986) Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer’s patches, mesenteric lymph nodes, and spleen. J Immunol 136: 152–156
Stanisz AM, Scicchitano R, Payan DG, Bienenstock J (1987a) In vitro studies of immunoregulation of substance P and somatostatin. Ann NY Acad Sci 496: 217–225
Stanisz AM, Scicchitano R, Dazin P, Bienenstock J, Payan DG (1987b) Distribution of substance P receptors on murine spleen and Peyer’s patch T- and B-cells. J Immunol 139: 749–754
Stephanou A, Jessop DS, Knight RA, Lightman SL (1990) Corticotropin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 4: 67–73
Theoharides TC, Douglas WW (1981) Mast cell histamine secretion in response to somatostatin analogues: structural considerations. Eur J Pharmacol 73: 131–136
Van Epps D, Saland L (1984) ß-Endorphin and Met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 132: 3046–3053
Weigent DA, Blalock JE (1987) Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev 100: 79–108
Weigent DA, Blalock JE (1990) Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol 29: 1–13
Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE (1988) Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 2: 2812–2818
Weinstock JV, Blum AM (1990) Release of substance P by granuloma eosinophils in response to secretagogues in murine Schistosomiasis mansoni. Cell Immunol 125: 380–385
Wenger GD, O’Dorisio MS (1990) Vasoactive intestinal peptide: messenger in a neuroimmune axis. Ann NY Acad Sci 594: 104–119
Westley HJ, Kleiss AJ, Kelley KW, Wong PKY, Yuen P-H (1986) Newcastle’s disease virus-infected splenocytes express the pro-opiomelanocortin gene. J Exp Med 163: 1589–1594
Woloski BMRNJ, Smith EM, Meyer WJ III, Fuller GM, Blalock JE (1985) Corticotropinreleasing activity of monokines. Science 23: 1035–1037
Yasuda N, Greer MA, Azizawa T (1982) Corticotropin-releasing factor. Endocr Rev 3: 123
Zelazowski P, Dohler KD, Stepien H, Pawlikowski M (1989) Effect of growth hormone releasing hormone on human peripheral blood leukocyte chemotaxis and migration in normal subjects. Neuroendocrinology 50: 236
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Weigent, D.A., Blalock, J.E. (1994). Role of Neuropeptides in the Bidirectional Communication Between the Immune and Neuroendocrine Systems. In: Scharrer, B., Smith, E.M., Stefano, G.B. (eds) Neuropeptides and Immunoregulation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78480-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-78480-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78482-8
Online ISBN: 978-3-642-78480-4
eBook Packages: Springer Book Archive